A small-molecule NNMT inhibitor that raises NAD+ and supports mitochondrial function and fat metabolism.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 5 mg vial takes 0.5 mL of water for a clean 10 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration |
|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL |
| 50 mg | 5 mL | 10 mg/mL |
Units are shown for a U-100 insulin syringe. 5-Amino-1MQ is a blend, so a single verified per-injection mark is not published; dosing follows the specific protocol.
Inhibits NNMT, elevating NAD+ and improving mitochondrial function while reducing lipogenesis.
5-Amino-1MQ is commonly taken in the morning.
Add 0.5 mL of bacteriostatic water to a 5 mg 5-Amino-1MQ vial for a 10 mg/mL solution.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the 5-Amino-1MQ vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.